What We Can Really Do with Bioresponsive MRI Contrast Agents.

Bioresponsive MRI contrast agents hold great promise for monitoring major physiological and pathological processes in a non-invasive manner. They are capable of altering the acquired MRI signal as a consequence of changes in their microenvironment, thus allowing real-time functional reporting in living organisms. Importantly, chemistry offers diverse solutions for the design of agents which respond to a great number of specific targets. However, the path to the successful utilization of these biomarkers in the desired functional MRI studies involves careful consideration of multiple scientific, technical, and practical issues across various research disciplines. This Minireview highlights the critical steps for planning and executing such multidisciplinary projects with an aim to substantially improve our knowledge of essential biological processes.

[1]  J. Kermode,et al.  Macroscopic scattering of cracks initiated at single impurity atoms , 2013, Nature Communications.

[2]  Zoltán Kovács,et al.  Hyperpolarized 89Y complexes as pH sensitive NMR probes. , 2010, Journal of the American Chemical Society.

[3]  Nirbhay N. Yadav,et al.  Single 19F Probe for Simultaneous Detection of Multiple Metal Ions Using miCEST MRI , 2014, Journal of the American Chemical Society.

[4]  J. Morrow,et al.  A redox-activated MRI contrast agent that switches between paramagnetic and diamagnetic states. , 2013, Angewandte Chemie.

[5]  Edward A. Randtke,et al.  A catalyCEST MRI contrast agent that detects the enzyme-catalyzed creation of a covalent bond. , 2013, Journal of the American Chemical Society.

[6]  I. Kuprov,et al.  19F NMR based pH probes: lanthanide(III) complexes with pH-sensitive chemical shifts. , 2008, Chemical communications.

[7]  Mikhail G. Shapiro,et al.  Genetically encoded reporters for hyperpolarized xenon magnetic resonance imaging. , 2014, Nature chemistry.

[8]  Mathias Hoehn,et al.  Labeling cells for in vivo tracking using (19)F MRI. , 2012, Biomaterials.

[9]  François Berthiaume,et al.  Tissue Engineering and Regenerative Medicine : History , Progress , and Challenges , 2013 .

[10]  Marie C. Heffern,et al.  Lanthanide probes for bioresponsive imaging. , 2014, Chemical reviews.

[11]  Craig S. Levin,et al.  New Imaging Technologies to Enhance the Molecular Sensitivity of Positron Emission Tomography , 2008, Proceedings of the IEEE.

[12]  Katherine S. Lovejoy,et al.  Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing , 2007, Proceedings of the National Academy of Sciences.

[13]  Enzo Terreno,et al.  Novel pH-reporter MRI contrast agents. , 2002, Angewandte Chemie.

[14]  A Dean Sherry,et al.  Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. , 2006, Chemical Society reviews.

[15]  R. Gobetto,et al.  Hyperpolarized agents for advanced MRI investigations. , 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[16]  A Dean Sherry,et al.  A new gadolinium-based MRI zinc sensor. , 2009, Journal of the American Chemical Society.

[17]  Itaru Hamachi,et al.  Self-assembling nanoprobes that display off/on 19F nuclear magnetic resonance signals for protein detection and imaging. , 2009, Nature chemistry.

[18]  A Dean Sherry,et al.  Noninvasive MRI of β-cell function using a Zn2+-responsive contrast agent , 2011, Proceedings of the National Academy of Sciences.

[19]  N. Logothetis,et al.  MRI sensing of neurotransmitters with a crown ether appended Gd(3+) complex. , 2015, ACS chemical neuroscience.

[20]  A Dean Sherry,et al.  Selective sensing of zinc ions with a PARACEST contrast agent. , 2005, Angewandte Chemie.

[21]  Enzo Terreno,et al.  Challenges for molecular magnetic resonance imaging. , 2010, Chemical reviews.

[22]  Rex Moats,et al.  EIN INTELLIGENTES REAGENS FUR DIE NMR-BILDGEBUNG ZUR BESTIMMUNG SPEZIFISCHER ENZYMATISCHER AKTIVITAT , 1997 .

[23]  Alan P. Koretsky,et al.  Is there a path beyond BOLD? Molecular imaging of brain function , 2012, NeuroImage.

[24]  H. Nonaka,et al.  A platform for designing hyperpolarized magnetic resonance chemical probes , 2013, Nature Communications.

[25]  M. Shirakawa,et al.  19F MRI detection of β-galactosidase activity for imaging of gene expression , 2011 .

[26]  Nirbhay N. Yadav,et al.  Chemical exchange saturation transfer (CEST): What is in a name and what isn't? , 2011, Magnetic resonance in medicine.

[27]  O. Togao,et al.  Multi-chromatic pH-activatable 19F-MRI nanoprobes with binary ON/OFF pH transitions and chemical-shift barcodes. , 2013, Angewandte Chemie.

[28]  N. Logothetis.  What we can do and what we cannot do with fMRI , 2008, Nature.

[29]  S. Fraser,et al.  A Calcium-Sensitive Magnetic Resonance Imaging Contrast Agent , 1999 .

[30]  J. Bulte,et al.  Fluorine (19F) MRS and MRI in biomedicine , 2011, NMR in biomedicine.

[31]  T. Soesbe,et al.  Advantages of paramagnetic chemical exchange saturation transfer (CEST) complexes having slow to intermediate water exchange properties as responsive MRI agents , 2013, NMR in biomedicine.

[32]  I. Dmochowski,et al.  A "Smart" ¹²⁸Xe NMR Biosensor for pH-Dependent Cell Labeling. , 2015, Journal of the American Chemical Society.

[33]  Scott E. Fraser,et al.  A SMART MAGNETIC RESONANCE IMAGING AGENT THAT REPORTS ON SPECIFIC ENZYMATIC ACTIVITY , 1997 .

[34]  M. Allen,et al.  Overcoming the concentration-dependence of responsive probes for magnetic resonance imaging. , 2015, Metallomics : integrated biometal science.

[35]  P. Durand,et al.  Detection of enzymatic activity by PARACEST MRI: a general approach to target a large variety of enzymes. , 2008, Angewandte Chemie.

[36]  H. Grüll,et al.  Bioresponsive probes for molecular imaging: concepts and in vivo applications. , 2015, Contrast media & molecular imaging.

[37]  Mark D Pagel,et al.  A review of responsive MRI contrast agents: 2005-2014. , 2015, Contrast media & molecular imaging.

[38]  Ambika Bumb,et al.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. , 2010, Chemical reviews.

[39]  Clemens Burda,et al.  The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. , 2012, Chemical Society reviews.

[40]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Scott E. Fraser,et al.  In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.

[42]  A. Jasanoff,et al.  Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin , 2006, Proceedings of the National Academy of Sciences.

[43]  R. Gillies,et al.  Responsive MRI agents for sensing metabolism in vivo. , 2009, Accounts of chemical research.

[44]  R. Kennedy,et al.  Review of recent advances in analytical techniques for the determination of neurotransmitters. , 2009, Analytica chimica acta.

[45]  N. Logothetis,et al.  Dual-frequency calcium-responsive MRI agents. , 2014, Chemistry.

[46]  Éva Tóth,et al.  The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging , 2013 .

[47]  Andrew M. Blamire,et al.  Moving the goal posts: enhancing the sensitivity of PARASHIFT proton magnetic resonance imaging and spectroscopy , 2013 .

[48]  Mikhail G. Shapiro,et al.  Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine , 2010, Nature Biotechnology.

[49]  Joël Janin,et al.  Physical biology of the cell, Second Edition , 2013 .

[50]  Aviad Hai,et al.  Molecular-Level Functional Magnetic Resonance Imaging of Dopaminergic Signaling , 2014, Science.

[51]  K. Brindle.  Imaging metabolism with hyperpolarized (13)C-labeled cell substrates. , 2015, Journal of the American Chemical Society.

[52]  A. Sherry,et al.  A responsive europium(III) chelate that provides a direct readout of pH by MRI. , 2010, Journal of the American Chemical Society.

[53]  Markus Wälchli,et al.  Paramagnetic relaxation-based 19f MRI probe to detect protease activity. , 2008, Journal of the American Chemical Society.

[54]  I. Kuprov,et al.  Lanthanide Complexes as Paramagnetic Probes for 19F Magnetic Resonance , 2012 .

[55]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[56]  R. Mason,et al.  New frontiers and developing applications in 19F NMR. , 2013, Progress in nuclear magnetic resonance spectroscopy.

[57]  Jeff W. M. Bulte,et al.  Molecular and Cellular MR Imaging , 2007 .